Once again, Eli Lilly has taken a major step towards managing supply chain woes. Today, the FDA approved the manufacturing, use, and labeling instructions for single-dose vial-packaged and standard syringe administered Tirzepatide. More can be found here:
So what does this mean for you? Patients will now have the ability to obtain single dose Mounjaro in vials, and will be able to load that dose into a syringe for administration. Check out this quick video to learn what this ultimately means for patients on Mounjaro.
Sneak peek at the instructions:
Comments